Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma-Reference-Cited by-同舟云学术

Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma

Published:2008-11-24 Issue:9 Volume:43 Page:701-708
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hicks L K,Woods A,Buckstein R,Mangel J,Pennell N,Zhang L,Imrie K,Spaner D,Cheung M C,Boudreau A,Reis M,Crump M,Berinstein N L

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2008382.pdf

Reference61 articles.

1. Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP . New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447–8452.

2. Weaver CH, Schwartzberg L, Rhinehart S, West J, Zhen B, West WH et al. High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1998; 21: 383–389.

3. Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau JP et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 86: 3257–3262.

4. Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H . Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. Eur J Haematol 2000; 65: 17–22.

5. Bierman PJ, Vose JM, Anderson JR, Bishop MR, Kessinger A, Armitage JO . High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445–450.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing – similar clinical efficacy with decreased immunoglobulin M deficiency rates;Multiple Sclerosis and Related Disorders;2023-11

2. Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia;Neuromuscular Disorders;2022-08

3. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees;Journal of Allergy and Clinical Immunology;2022-05

4. Long‐term outcome in patients with follicular lymphoma following high‐dose therapy and autologous stem cell transplantation;European Journal of Haematology;2021-08-03

5. Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia;Autoimmunity Reviews;2020-03